PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Molecular Medicine, Mayo Clinicgrid.66875.3a, Rochester, Minnesota, USA.\', \'Discovery Engine/Program for Hypoplastic Left Heart Syndrome, Mayo Clinicgrid.66875.3a, Rochester, Minnesota, USA.\', \'Influenza Research Institute, Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.\', \'Mayo Microscopy and Cell Analysis Core, Mayo Clinicgrid.66875.3a, Rochester, Minnesota, USA.\', \'Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1128/JVI.01368-21
?:hasPublicationType
?:journal
  • Journal of virology
is ?:pmid of
?:pmid
?:pmid
  • 34613786
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.853
?:rankingScore_hIndex
  • 268
is ?:relation_isRelatedTo_publication of
?:title
  • Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all